The Islamic Republic of Iran has continued its pursuit of obtaining a nuclear weapon by not only stockpiling enriched uranium to near-weapons grade purity, it has expanded its covert actions in developing its weaponization capabilities. According to information obtained by sources embedded in the Iranian regime and supplied to the…
HIGHLIGHTS BBM trend now extends over 15km, from Awalé’s 100%-owned Fremen target in the south to the Boba and Fett targets in the north. Boba and Fett have been defined along strike from BBM, highlighting the fertile and open BBM trend. 150 line-km of Induced Polarization (‘IP’) geophysics is planned…
AgTech Company highlights recent 100% purchase of Hemp Carbon Standard platform to advance industrial hemp carbon credits global market opportunity Hempalta Corp. (TSXV: HEMP) (‘Hempalta’ or the ‘Company’) has released its financial results for the year ended September 30, 2024. Hempalta’s audited consolidated financial statements (the ‘Financial Statements’) and related…
(TheNewswire) December 19th, 2024 TheNewswire – Vancouver, B.C. Opawica Explorations Inc. (TSXV: OPW) (FSE: A2PEAD) (OTCQB: OPWEF) (the ‘Company’ or ‘Opawica’) a Canadian mineral exploration company focused on precious and base metal projects, is pleased to announce that select members of it exploration personnel has been mobilized to conduct field…
Forum Energy Metals Corp. (TSXV: FMC) (OTCQB: FDCFF) (‘Forum’ or the ‘Company’) announced today that the Company is not aware of any undisclosed material information that might be contributing to the recent decline in the Company’s share price. As announced in its news release dated December 16th, 2024, the Company…
Cardiol Therapeutics President and CEO, David Elsley PRISM MarketView announces the release of an informative interview with Cardiol Therapeutics President and CEO, David Elsley, who discusses the company’s lead oral drug, CardiolRx, which is entering a late-stage Phase III clinical trial, MAVERIC, for patients with recurrent pericarditis who are at…
Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial Download the PDF here. This post appeared first on investingnews.com
Westgold Resources (ASX:WGX,TSX:WGX,OTCQX:WGXRF) has completed a scoping study that evaluates an expansion of its Fortnum gold operation in Western Australia, the company said on Tuesday (December 17). The study forms part of the company’s portfolio review, and shows a potential 10 year, fully integrated mine plan. It outlines life-of-mine production…
After trending down in 2023, nickel prices climbed to a 10 month high in late May of this year. However, they’ve since pulled back to four-year lows. While this environment has been tough for nickel companies, some stocks are still thriving. Supply is expected to outflank demand over the short…
Cyprium Metals Limited (ASX: CYM, OTC: CYPMF) (Cyprium or the Company) is pleased to announce the successful completion of Tranche 1 of the two-tranche placement to raise in aggregate A$13.5 million (before costs) via the issue of a total of 483,203,140 fully paid ordinary shares in the Company (Placement Shares)…